HIGHLIGHTS
- who: Patricia Nezan from the Department Adresse: RandD UNICANCER, rue de Tolbiac, PARIS , France have published the research: : 0105-1305 : 2013-001653-27 Evaluation of the efficacy of high throughput genome analysis as therapeutic decision tool for patients with metastatic non-small cell cancer th, in the Journal: (JOURNAL) of 14/03/2017
- what: The aim of the study is to demonstrate that targeted therapeutic approach in substudy guided by the genomic analysis (arm A1) improves progression-free survival as compared to a non-targeted maintenance therapy (arm B1). IMMUNOTHERAPIES IN ONCOLOGY RATIONALE TO DEVELOP . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.